Search research articles
Contact Us
Filters
Showing results (701-710 of 842) with videos related to
Page
of 85
Sort By:
Blood Advances
|
September 11, 2020
A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data
Ti-Cheng Chang, Kelly M Haupfear, Jing Yu, et al.
Molecular Oncology
|
September 16, 2021
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
Iben Lyskjaer, Christopher Davies, Anna-Christina Strobl, et al.
Cancer Medicine
|
August 24, 2017
Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection
Alice Gutteridge, Victoria M Rathbone, Rebecca Gibbons, et al.
Blood Cells, Molecules & Diseases
|
November 14, 2016
The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil
João Ricardo Friedrisch, Vivien Sheehan, Jonathan M Flanagan, et al.
Plos One
|
October 7, 2016
Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia
Beverly A Schaefer, Jonathan M Flanagan, Ofelia A Alvarez, et al.
The Journal of Pathology. Clinical Research
|
May 5, 2021
DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'
Iben Lyskjaer, Solange De Noon, Roberto Tirabosco, et al.
British Journal of Haematology
|
January 18, 2006
Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain
Núria Noel, Jonathan M Flanagan, John Flanagan, et al.
Cancer Medicine
|
May 28, 2014
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
M Fernanda Amary, Hongtao Ye, Fitim Berisha, et al.
Genome Biology
|
November 27, 2025
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma
William Cross, Iben Lyskjær, Christopher Davies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 31, 2021
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor
Florian Puls, Jodi M Carter, Nischalan Pillay, et al.
Page
of 85
Search research articles
Search
Showing results (701-710 of 842) with videos related to
Sort By:
Page
of 85
Blood Advances
|
September 11, 2020
A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data
Ti-Cheng Chang, Kelly M Haupfear, Jing Yu, et al.
Molecular Oncology
|
September 16, 2021
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
Iben Lyskjaer, Christopher Davies, Anna-Christina Strobl, et al.
Cancer Medicine
|
August 24, 2017
Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection
Alice Gutteridge, Victoria M Rathbone, Rebecca Gibbons, et al.
Blood Cells, Molecules & Diseases
|
November 14, 2016
The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil
João Ricardo Friedrisch, Vivien Sheehan, Jonathan M Flanagan, et al.
Plos One
|
October 7, 2016
Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia
Beverly A Schaefer, Jonathan M Flanagan, Ofelia A Alvarez, et al.
The Journal of Pathology. Clinical Research
|
May 5, 2021
DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'
Iben Lyskjaer, Solange De Noon, Roberto Tirabosco, et al.
British Journal of Haematology
|
January 18, 2006
Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain
Núria Noel, Jonathan M Flanagan, John Flanagan, et al.
Cancer Medicine
|
May 28, 2014
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
M Fernanda Amary, Hongtao Ye, Fitim Berisha, et al.
Genome Biology
|
November 27, 2025
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma
William Cross, Iben Lyskjær, Christopher Davies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 31, 2021
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor
Florian Puls, Jodi M Carter, Nischalan Pillay, et al.
Page
of 85